Docusign (NASDAQ:DOCU) Insider Robert Chatwani Sells 983 Shares of Stock

Docusign Inc. (NASDAQ:DOCU) insider Robert Chatwani sold 983 shares of the business’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $68.62, for a total value of $67,453.46. Following the completion of the transaction, the insider owned 70,179 shares of the company’s stock, valued at $4,815,682.98. This represents a 1.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Robert Chatwani also recently made the following trade(s):

• On Wednesday, September 17th, Robert Chatwani sold 13,817 shares of Docusign stock. The shares were sold at an average price of $83.10, for a total value of $1,148,192.70.
• On Monday, September 15th, Robert Chatwani sold 1,682 shares of Docusign stock. The stock was sold at an average price of $80.30, for a total value of $135,064.60.

Docusign Stock Performance

Shares of NASDAQ:DOCU opened at $71.11 on Friday. The firm has a market cap of $14.24 billion, a price-to-earnings ratio of 49.73, a price-to-earnings-growth ratio of 3.53 and a beta of 0.98. The business has a 50-day simple moving average of $69.18 and a two-hundred day simple moving average of $74.68. Docusign Inc. has a fifty-two week low of $63.41 and a fifty-two week high of $99.71.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on DOCU. Morgan Stanley raised their target price on shares of Docusign from $86.00 to $90.00 and gave the stock an “equal weight” rating in a report on Monday, September 8th. Needham & Company LLC restated a “hold” rating on shares of Docusign in a research note on Friday, December 5th. Zacks Research lowered Docusign from a “strong-buy” rating to a “hold” rating in a report on Monday, November 24th. JMP Securities reissued a “market outperform” rating and issued a $124.00 target price on shares of Docusign in a report on Friday, October 3rd. Finally, JPMorgan Chase & Co. lowered their target price on Docusign from $80.00 to $78.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Four research analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $86.71.

Institutional Investors Weigh In On Docusign

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DOCU. Banque Transatlantique SA purchased a new position in Docusign during the first quarter valued at approximately $26,000. Summit Securities Group LLC purchased a new position in shares of Docusign during the 1st quarter valued at $34,000. Rise Advisors LLC lifted its stake in shares of Docusign by 864.6% during the 1st quarter. Rise Advisors LLC now owns 463 shares of the company’s stock valued at $38,000 after buying an additional 415 shares in the last quarter. WPG Advisers LLC bought a new position in Docusign in the 1st quarter worth $39,000. Finally, Twin Peaks Wealth Advisors LLC purchased a new stake in Docusign in the 2nd quarter worth $43,000. 77.64% of the stock is owned by hedge funds and other institutional investors.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.